Asthma-related death, acutely deteriorating asthma & treatment of acute symptoms. CV or CNS disorders. Convulsive disorders, thyrotoxicosis, DM & ketoacidosis. Combination w/ additional long-acting β2
-agonist & strong CYP450 3A4 inhibitors. Monitor for signs of oral cavity & lung infections. Close monitoring is warranted for glaucoma & cataracts. Potential worsening of infections. Taper slowly if transferring from systemic corticosteroids. Hypercorticism & adrenal suppresion. Discontinue use in paradoxical bronchospasm. Assess bone mineral density initially & periodically thereafter. Hypoglycemia & hyperglycemia. Monitor growth in childn. Pregnancy & lactation.